Fundz

Sir Pant Immunotherapeutics, Inc. reported raising $27.1 Million in an initial SEC Form D filing, from an offering of $25.1 Million

PRIVATEAug 05, 2021

Amount Raised

$27.1 Million

$27.1 Million sold, per SEC Form D (first sale Aug 5, 2021)

Round Type

Venture

HummelstownBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as BobcatBio that raised within 45 days of this round, from Fundz verified event records.

  • Triana Biomedicines raised $10M on September 17, 2021.
  • Enkefalos Biosciences, Inc. raised $1.5M (Seed) on September 17, 2021.
  • Membrion raised $3M (Seed) on September 17, 2021.
  • NEXGEL raised $1.6M (Seed) on September 17, 2021.
  • Biolinq raised $62M on September 17, 2021.
  • Iaso Bio raised $108M (Series C) on September 16, 2021.

Who to call at BobcatBio, and when

A new round usually means BobcatBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BobcatBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BobcatBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BobcatBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BobcatBio

Location

1214 RESEARCH BOULEVARD, SUITE 2010

Hummelstown, Pennsylvania, United States

About

BobcatBio, Inc. was formerly known as SIRPant Immunotherapeutics Inc. BobcatBio is spearheading the development of macrophage-based cell therapies for the treatment of solid tumors. Leveraging our deep understanding of the biology of myeloid cells—the cells that drive immune responses—BobcatBio engineers specially-equipped macrophages from a patient’s own blood cells without any genetic modifications and then provides those cells back to the patient.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BobcatBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for BobcatBio's next move

See what Strategic adds

BobcatBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.